Jérôme Tamburini studied medicine in Paris (Université Paris Descartes) and specialised in clinical haematology. He holds a ...

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

How did digits evolve? While it is clear that they derive from genetic programs already present in fish, their precise origin ...

While the telephone brought comfort, smartphones changed lives. While factories powered economies, artificial intelligence ...

Hybrid seed production is vital for enhancing crop yield and quality, yet conventional methods in rapeseed are limited by inefficiency and high costs.

Resveratrol, a plant-derived compound celebrated for its antioxidant and therapeutic potential, has long been limited by ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...